Atlanta residents rely on prescription package inserts for information about the drug that they will be taking. In the U.S., the Food and Drug Administration regulates what kind of information is required to be on the inserts. This typically includes sections related to what the drug is used for, warnings and side effects, when the drug should not be used and precautions. This is done in order to educate the person taking the medication about what he or she may expect.
A woman who suffered adverse reactions from using the NuvaRing birth control system is suing, saying that the package insert did not give proper warning about the risk of venous thromboembolism. Instead, her complaint alleges that the insert contained information that came from studies conducted on birth control pills, not from studies of NuvaRing.
The woman began using NuvaRing around March 2012 when she was 41 years old. Approximately a month later, she began to suffer from shortness of breath and chest discomfort. A visit to her cardiologist and a CT scan confirmed that she had a pulmonary embolism in her right lung. She was hospitalized immediately and started on anticoagulation therapy.
She recently filed a products liability lawsuit against the makers of the birth control system, claiming that her pulmonary embolism was caused by NuvaRing. She is suing for over $75,000 along with her attorneys’ fees and costs.
The woman will continue to need medical care and medications for her condition. Hopefully her lawsuit will enable to receive the compensation she deserves for her pain and suffering and costs associated with her medical care.
Source: The Pennsylvania Record, “York Co. woman files NuvaRing products liability complaint,” Jon Campisi, Nov. 18, 2013